Neurocognitive Assessment And Rehabilitation Market (2025 - 2030)

Neurocognitive Assessment And Rehabilitation Market Summary

The rising incidence of neurological conditions such as stroke, multiple sclerosis, Parkinson’s disease, cerebral palsy, acquired brain injury, and neurodevelopmental disorders is increasing the demand for neurocognitive assessment and neurorehabilitation. Moreover, favorable government initiatives to advance neurocognitive assessment are expected to propel market growth.

A study supported by the Parkinson's Foundation in 2022 found that the number of people diagnosed with Parkinson's disease in the U.S. has increased by 50% compared to previous estimates. The disease affects nearly 90,000 people in the country every year. Meanwhile, according to a report by the National Institute of Health (NIH), dementia remains a significant public health challenge, with approximately 1.8 million people affected in Germany by the end of 2021. In that year alone, over 360,000 to 440,000 new cases were reported. It is projected that by 2033, the number of people aged 65 and over, with dementia, could increase to as many as 2 million. An increasing number of patients with various health conditions is expected to drive growth in the neurocognitive assessment and rehabilitation market.

As per the American Association for the Advancement of Science (AAAS) report, in 2023, the U.S. Army Medical Research Acquisition Activity division of the Department of Defense (DOD) granted USD 1.5 million to develop a portable virtual reality device system. This system can quickly and accurately assess multiple neurocognitive domains in real-time.

Market Concentration & Characteristics

Technological innovation in the industry, including Virtual Reality (VR), Artificial Intelligence (AI), and wearable devices, have significantly enhanced the accuracy & effectiveness of neurocognitive assessments, contributing to the market’s growth. With these tools, healthcare professionals can gather more comprehensive and real-time data to understand patients’ neurocognitive functions accurately.

Several market players, such as CogniFit, Cogstate Ltd., Cognetivity Neurosciences, BrainCheck, Inc., and Clario are constantly involved in partnership & collaboration and M&A activities to expand their geographic presence and service offerings.

Favorable government policies and laws to ensure the safety & efficacy of neurocognitive assessment and rehabilitation services are expected to support the market growth. Hence, market players have to adhere to local or regional regulations. This is expected to reduce the scope of regional expansion as the companies must adhere to different regional regulations.

The level of regional expansion is moderate in the market owing to changes in regulatory frameworks, specific demand of the target population, and the unorganized nature of the industry in many low-and middle-income countries.

Providers Insights

The rehab centers segment dominated the market in 2023. Neurocognitive assessments in rehab centers help customize rehabilitation plans by identifying cognitive strengths & challenges. This enhances the effectiveness of interventions for individuals recovering from neurological injuries or surgeries. Regular neurocognitive testing allows healthcare professionals in rehabilitation centers to monitor cognitive function changes over recovery.

The homecare settings segment is expected to witness the fastest growth over the forecast period. This can be attributed to the increasing demand for in-home neurocognitive assessments driven by factors such as convenience for caregivers, preventive care focus, individualized treatment plans, pandemic-related changes, and improved technology integration.

Regional Insights

North America region held the largest market share of over 31% in 2023. This can be attributed to a strong emphasis on research & development in the healthcare sector. The region’s robust ecosystem of research institutions, medical universities, and private industry players is expected to foster continuous innovation in neurocognitive technologies. Moreover, collaborations between academia and healthcare industry facilitate the rapid development and adoption of advanced assessment & rehabilitation tools. For instance, in March 2022, Altoida, a neurology assessment company based in D.C., recently raised USD 20.3 million in Series A funding. The company uses Artificial Intelligence (AI) and Augmented Reality (AR) to enhance traditional neurocognitive assessments.

Asia Pacific is expected to witness the fastest growth over the forecast period. Asia Pacific market is primarily driven by the rising geriatric population and increasing incidence of neurological disorders. Countries, such as China, Japan, South Korea, and India, are expected to witness considerable growth over the forecast period. The presence of several local players in China and Japan is expected to boost the market.

Component Insights

The neurorehabilitation therapy segment dominated the market with a revenue share of over 62% in 2023. The segment growth is driven primarily by the high prevalence of neurological disorders, rising geriatric population, and technological developments in neurorehabilitation devices. According to reports by the National Library of Medicine in 2023, approximately 15% of the global population is presently affected by neurological illnesses, which are the primary cause of physical & cognitive disabilities.

The neurocognitive assessment testing segment is expected to witness the fastest growth over the forecast period. This can be attributed to the increasing prevalence of cognitive disorders such as dementia, traumatic brain injury, and others. As per a study conducted by Columbia University in October 2022, 10% of Americans aged 65 and older had dementia. In addition, it revealed that 22% of Americans of the same age suffered from mild cognitive impairment.

Key Companies & Market Share Insights

The market is highly fragmented, with the presence of many country-level players. However, as demand for quality services grows, existing providers may boost competition by offering innovative programs or expanding their products and services. The presence of established players, stringent regulatory compliance, and the need for continuous technological innovations contribute to high rivalry in the market.

• Cambridge Cognition Ltd, SCHUHFRIED GmbH (CogniPlus), Cogstate Ltd,Cognetivity, and Neuroscience, are some of the dominant players operating in the market.

• Cognetivity Neuroscience is a technology firm that has created a cognitive assessment platform for application in medical, commercial, and consumer settings.

• Cambridge Cognition Ltd develops and markets neuroscience tools for evaluating cognitive function worldwide, primarily in the UK, the U.S., and Europe.

• NeuronUp, BrainCheck, Inc., and Posit Science are some of the emerging market players functioning in market.

• Posit Science is a provider of brain training & cognitive assessment software. The company develops evidence-based, clinically proven programs that improve cognitive function and brain health.

• BrainCheck offers a health assessment and management application that connects patients & care teams in the dementia and concussion markets.

Recent Developments

• In October 2023, BrainCheck, Inc. launched the latest platform called BrainCheck Screen at the Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston, Massachusetts.

• In October 2023, Cognetivity Neurosciences partnered with Mediclinic to provide a cognitive assessment to those over 50 years. This program was aimed at identifying age-related brain health issues early, allowing for timely & coordinated care.

Neurocognitive Assessment And Rehabilitation Market